Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Return on Capital Employed (2016 - 2025)

Iradimed (IRMD) has disclosed Return on Capital Employed for 12 consecutive years, with 0.25% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed changed 0.0% to 0.25% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.25%, a 0.0% change, with the full-year FY2024 number at 0.25%, down 2.0% from a year prior.
  • Return on Capital Employed was 0.25% for Q3 2025 at Iradimed, up from 0.25% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.27% in Q4 2023 to a low of 0.0% in Q1 2021.
  • A 5-year average of 0.2% and a median of 0.24% in 2023 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: decreased -12bps in 2021, then rose 15bps in 2022.
  • Iradimed's Return on Capital Employed stood at 0.13% in 2021, then soared by 59bps to 0.21% in 2022, then grew by 29bps to 0.27% in 2023, then dropped by -8bps to 0.25% in 2024, then increased by 2bps to 0.25% in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Return on Capital Employed are 0.25% (Q3 2025), 0.25% (Q2 2025), and 0.25% (Q1 2025).